Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3TZM

TGF-beta Receptor type 1 in complex with SB431542

3TZM の概要
エントリーDOI10.2210/pdb3tzm/pdb
分子名称TGF-beta receptor type-1, 4-[5-(1,3-benzodioxol-5-yl)-4-(pyridin-2-yl)-1H-imidazol-2-yl]benzamide (3 entities in total)
機能のキーワードalk5, sb431542, kinase domain, transferase-transferase inhibitor complex, transferase/transferase inhibitor
由来する生物種Homo sapiens (human)
細胞内の位置Cell membrane; Single-pass type I membrane protein: P36897
タンパク質・核酸の鎖数1
化学式量合計35612.94
構造登録者
Ogunjimi, A.A.,Zeqiraj, E.,Ceccarelli, D.F.,Sicheri, F. (登録日: 2011-09-27, 公開日: 2012-05-23, 最終更新日: 2023-09-13)
主引用文献Ogunjimi, A.A.,Zeqiraj, E.,Ceccarelli, D.F.,Sicheri, F.,Wrana, J.L.,David, L.
Structural Basis for Specificity of TGFbeta Family Receptor Small Molecule Inhibitors
Cell Signal, 24:476-483, 2012
Cited by
PubMed Abstract: Transforming growth factor-β (TGFβ) receptor kinase inhibitors have a great therapeutic potential. SB431542 is one of the mainly used kinase inhibitors of the TGFβ/Activin pathway receptors, but needs improvement of its EC(50) (EC(50)=1 μM) to be translated to clinical use. A key feature of SB431542 is that it specifically targets receptors from the TGFβ/Activin pathway but not the closely related receptors from the bone morphogenic proteins (BMP) pathway. To understand the mechanisms of this selectivity, we solved the crystal structure of the TGFβ type I receptor (TβRI) kinase domain in complex with SB431542. We mutated TβRI residues coordinating SB431542 to their counterparts in activin-receptor like kinase 2 (ALK2), a BMP receptor kinase, and tested the kinase activity of mutated TβRI. We discovered that a Ser280Thr mutation yielded a TβRI variant that was resistant to SB431542 inhibition. Furthermore, the corresponding Thr283Ser mutation in ALK2 yielded a BMP receptor sensitive to SB431542. This demonstrated that Ser280 is the key determinant of selectivity for SB431542. This work provides a framework for optimising the SB431542 scaffold to more potent and selective inhibitors of the TGFβ/Activin pathway.
PubMed: 21983015
DOI: 10.1016/j.cellsig.2011.09.027
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.7 Å)
構造検証レポート
Validation report summary of 3tzm
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon